Interview: Rexbio sets sights on novel approach to pancreatic cancer
This article was originally published in Scrip
Executive Summary
The South Korean bioventure Rexbio is looking to develop a novel approach to the treatment and diagnosis of one of the most deadly forms of cancer by targeting a gene found to be closely linked to the malignancy.